• Bruce Canter
    S​​​​​​enior Vice President - Law, General Counsel and MicroVention’s Chief Compliance Officer

     

     

  • MicroVention is a member of AdvaMed and MedTech. To learn more about these medical technology associations and the codes we have adopted, you may visit the third party external websites listed below

  • The Ethics Hotline is not yet available in EMEA

    MicroVention expects its associates and business partners to act ethically and in accordance with all applicable laws and industry codes.

    We have a global helpline, www.terumointegrity.com, where good faith concerns about the conduct or practices of MicroVention, its associates or business partners may be reported. The telephone number to reach our helpline varies from country to country – see the below full list of helpline numbers. This confidential and anonymous tool makes it easy to report, day or night, and is accessible via phone or internet.

    MicroVention also allows reporting to:

    1. any manager;

    2. to Human Resources;

    3. to a Company Executive;

    4. the Senior Vice President-Law or any other Company attorney; and/or

    5. the Company Compliance Officer or Compliance Promoter.

    MicroVention will take appropriate action, in its sole determination, in response to each report and the nature and extent of each action will depend, in part, on the nature of the concern.

    MicroVention prohibits harassment of, or retaliation against, any associate or other person who reports in good faith a known or suspected violation of law or of MicroVention policies.

     

    Helpline Country Numbers:
    Argentina:  
    0800-222-4417
    Australia:  1-300-027-655
    Austria:  0800-802708
    Belgium:  0800-745-44
    Brazil:  0-800-591-6017
    Canada:  1-800-205-654
    Chile:  800-914-389
    China(400-1):400-120-9159
    Colombia:  01800-710-2015
    Costa Rica:  -40014640
    Denmark:  8082-0309
    Finland:  0800-915-764
    France:  0805-080232
    Germany:  0800-180-6591
    Hong Kong:  800-906-073
    India:  000-800-100-4152
    Indonesia:  001-803-015-203-9782
    Ireland:  1-800-902-285
    Italy:  800-136-850
    Japan:    0800-222-0399
    Korea:   080-808-0962
    Malaysia:   1-800-817-793
    Mauritius:   720-904-7205
    Mexico:   01-800-099-0687
    Panama:   507-8338992
    Peru :  0800-78341
    Philippines:  63-2-2312143
    Poland:  0-0-800-141-0263
    Portugal:  800-180-437
    Puerto Rico:  1-800-210-8757
    Russia:  8-800-100-9684
    Scotland:  0-808-189-0972
    Singapore:  800-852-6118
    South Africa:  0-800-993-054
    Spain:  900-839236
    Sweden:  020-889-218
    Switzerland:  0800-893-904
    Taiwan, R.O.C.:  00801-85-6728
    Thailand:  001-800-852-5417
    Turkey:  90-850-7661495
    UAE:  8000-3570-3914
    United Kingdom:  0-808-189-0972
    United States:  1-800-261-9347
    Uruguay:  000-416-205-6405
    Venezuela:  0-800-102-9418
    Vietnam:  (122): 122-80-354

     

  • MicroVention considered requests for: education and research grants to the support genuine independent medical research for the advancement of medical science or education; and donations for charitable purposes to charitable entities. All grant and donation requests will be reviewed by the Grants and Donations Committee or the SVP-Law. Sales and marketing associates are not involved in the grant and donation review process and requests for follow-up or additional information should not be directed to these associates.

    If you are a healthcare professional or healthcare organization and desire to request a grant or donation from MicroVention, please submit your request on your organization's letterhead and include the amount or product requested and other relevant details about your organization and/or use of the funds/product requested. If the grant or donation relates to a program, please attach a copy of the program agenda and website information. If the request relates to independent research, please attach a copy of the protocol. All materials and letters must be submitted in English.

    Requests and supporting materials should be emailed to the below email addresses based on the location of the requestor:

    North America: Coming soon.

    China, Latin America, AsiaPac (CHAPLA): Coming soon.

    Europe, Middle East, Africa (EMEA): Please contact your local MicroVention contact for further instructions.

  • MicroVention complies with the US Federal Open Payments Act (also known as Sunshine Law) (Section 6002 of the Patient Protection and Affordable Care Act (Public Law No. 111-148), as amended by the Health Care and Education Reconciliation Act of 2010 (Public Law No. 111-152).

    Open Payments is a federal program, required by the Affordable Care Act, that collects information about the payments drug and device companies make to physicians and teaching hospitals for things like travel, research, gifts, speaking fees, and meals. It also includes ownership interests that physicians or their immediate family members have in these companies.  This data is then made available to the public each year on this website. More information about Open Payments can be found at https://www.cms.gov/openpayments/.

    If you have questions about MicroVention’s reporting under this law, please contact ussunshine@microvention.com.

  • This information is provided pursuant to the requirements of California Health & Safety Code § 119402, which requires certain pharmaceutical and medical device companies doing business in California to make available their program for compliance with applicable federal and state laws and industry standards regulating the marketing and promotion of their products.

    ANNUAL DESCRIPTION OF COMPREHENSIVE COMPLIANCE PROGRAM CALIFORNIA HEALTH & SAFETY CODE §§ 119400-119402 | May 1, 2017

    MicroVention, Inc. ("MicroVention") is committed to doing business in accordance with the highest standards of business conduct and ethics. We consider our reputation for ethical and compliant behavior to be a valuable corporate asset. Each employee of MicroVention is charged with the responsibility for safeguarding and strengthening that asset.

    MicroVention is dedicated to complying with U.S. federal and state laws and regulations that place certain restrictions and reporting requirements on interactions that MicroVention has with U.S. health care professionals and related organizations. Most notably, the Federal Physician Payment Sunshine Act requires MicroVention to annually report to the U.S. Centers for Medicare and Medicaid Services information about payments and other transfers of value that are provided to U.S. physicians and teaching hospitals. Payment types that are subject to reporting under this transparency law may include, consulting fees, meals, travel, charitable donations, payments related to clinical trials and research, and physician educational materials. MicroVention is committed to fulfilling its obligations to track and report these payments and transfers of value as required by U.S. law.

    In addition to complying with its obligations under U.S. federal and state transparency laws, MicroVention has established a Compliance Program in accordance with California Health and Safety Code, Division 104, Part 15, Chapter 8, Sections 119400‐119402 (the "Statute"), based on our good faith understanding of the requirements of the Statute as it may apply to a medical device manufacturer. MicroVention has developed a Compliance Program consistent with the Compliance Program Guidance for Pharmaceutical Manufacturers (which is expressly applicable to medical device manufacturers) published by the Office of Inspector General of the U.S. Department of Health and Human Services. Our Compliance Program is tailored to the size, organizational structure, nature of our business as a medical device manufacturer and resources of MicroVention. MicroVention's Compliance Program is designed to comply with the AdvaMed Code of Ethics on Interactions with Health Care Professionals (the "AdvaMed Code"). The AdvaMed Code is a voluntary ethical code established by the medical device industry. It is substantially similar to the Pharmaceutical Research and Manufacturers of America Code on Interactions with Healthcare Professionals, but reflects the unique interactions between medical device manufacturers and health care professionals. Further, as required by the Statute, MicroVention has an annual limit on promotional spending.

    While adoption of appropriate policies do not necessarily guarantee that improper individual conduct will be entirely eliminated, it is MicroVention's expectation that our associates comply with our Code of Conduct (the Sakura Rules), Comprehensive Corporate Compliance Program, Code of Ethics on Interactions with Healthcare Professionals and other policies and/or procedures as adopted from time to time in support of the AdvaMed Code. Furthermore, our Compliance Program has been designed to prevent and detect violations. In the event our MicroVention becomes aware of potential violations of law or MicroVention policy, MicroVention will, as appropriate, take appropriate action which may include investigating the matter, taking disciplinary action, and/or implementing corrective measures to prevent future violations. MicroVention periodically reassesses the Compliance Program to improve it, and may refine the elements as necessary.

    MicroVention, Inc. ("MicroVention") is committed to doing business in accordance with the highest standards of business conduct and ethics. We consider our reputation for ethical and compliant behavior to be a valuable corporate asset. Each employee of MicroVention is charged with the responsibility for safeguarding and strengthening that asset.

    MicroVention is dedicated to complying with U.S. federal and state laws and regulations that place certain restrictions and reporting requirements on interactions that MicroVention has with U.S. health care professionals and related organizations. Most notably, the Federal Physician Payment Sunshine Act requires MicroVention to annually report to the U.S. Centers for Medicare and Medicaid Services information about payments and other transfers of value that are provided to U.S. physicians and teaching hospitals. Payment types that are subject to reporting under this transparency law may include, consulting fees, meals, travel, charitable donations, payments related to clinical trials and research, and physician educational materials. MicroVention is committed to fulfilling its obligations to track and report these payments and transfers of value as required by U.S. law.

    In addition to complying with its obligations under U.S. federal and state transparency laws, MicroVention has established a Compliance Program in accordance with California Health and Safety Code, Division 104, Part 15, Chapter 8, Sections 119400‐119402 (the "Statute"), based on our good faith understanding of the requirements of the Statute as it may apply to a medical device manufacturer. MicroVention has developed a Compliance Program consistent with the Compliance Program Guidance for Pharmaceutical Manufacturers (which is expressly applicable to medical device manufacturers) published by the Office of Inspector General of the U.S. Department of Health and Human Services. Our Compliance Program is tailored to the size, organizational structure, nature of our business as a medical device manufacturer and resources of MicroVention. MicroVention's Compliance Program is designed to comply with the AdvaMed Code of Ethics on Interactions with Health Care Professionals (the "AdvaMed Code"). The AdvaMed Code is a voluntary ethical code established by the medical device industry. It is substantially similar to the Pharmaceutical Research and Manufacturers of America Code on Interactions with Healthcare Professionals, but reflects the unique interactions between medical device manufacturers and health care professionals. Further, as required by the Statute, MicroVention has an annual limit on promotional spending.

    While adoption of appropriate policies do not necessarily guarantee that improper individual conduct will be entirely eliminated, it is MicroVention's expectation that our associates comply with our Code of Conduct (the Sakura Rules), Comprehensive Corporate Compliance Program, Code of Ethics on Interactions with Healthcare Professionals and other policies and/or procedures as adopted from time to time in support of the AdvaMed Code. Furthermore, our Compliance Program has been designed to prevent and detect violations. In the event our MicroVention becomes aware of potential violations of law or MicroVention policy, MicroVention will, as appropriate, take appropriate action which may include investigating the matter, taking disciplinary action, and/or implementing corrective measures to prevent future violations. MicroVention periodically reassesses the Compliance Program to improve it, and may refine the elements as necessary.

    To access MicroVention, Inc.'s Corporate Compliance Program, click below.

    To obtain a hard copy of MicroVention, Inc.’s Compliance Program and/or written declaration of compliance, please call 1-800-990-8368 and ask for the Compliance Officer.
     

  • The California Transparency in the Supply Chains Act of 2010 requires certain manufacturers and retailers, including MicroVention, Inc. (the “Company”), to disclose their efforts to eradicate human trafficking and slavery from their supply chains. At this time, the Company does not independently verify its product supply chain or its direct suppliers for risks relating to human trafficking or slavery, nor for compliance with Company standards. Similarly, the Company does not require its suppliers to certify that they comply with the laws of the countries in which they are doing business. The Company does not provide its employees with training on human trafficking or slavery, nor does it maintain internal accountability standards or procedures related to the same.